Neurofibromatosis type 1

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:psychologist
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:psychologist
gptkbp:acquired genetic testing
gptkbp:affects gptkb:computer
any race or ethnicity
gptkbp:can_be chronic pain
gptkbp:can_lead_to psychosocial issues
neurofibromas
gptkbp:caused_by learning disabilities
tumors
gptkbp:complications hypertension
gptkbp:current_use varies in severity
requires lifelong monitoring.
gptkbp:descendant autosomal dominant
gptkbp:exhibits skeletal abnormalities
gptkbp:focuses_on clinical trials
gptkbp:has_achievements cardiovascular issues
endocrine disorders
scoliosis
https://www.w3.org/2000/01/rdf-schema#label Neurofibromatosis type 1
gptkbp:is_associated_with gptkb:optic_gliomas
seizures
vision problems
hearing loss
learning difficulties
gptkbp:is_characterized_by gptkb:plexiform_neurofibromas
neurofibromas
cafe-au-lait spots
gptkbp:is_discussed_in gptkb:academic_journal
gptkbp:is_evaluated_by psychological impact
neurological function
gptkbp:is_featured_in patient stories
gptkbp:is_known_for N F1
gptkbp:is_linked_to cognitive challenges
N F1 gene
gptkbp:is_monitored_by malignant peripheral nerve sheath tumors
gptkbp:is_often_associated_with genetic screening programs
gptkbp:is_often_depicted_as other genetic syndromes
gptkbp:is_often_used_in both sexes equally
gptkbp:is_part_of neurofibromatosis disorders
gptkbp:is_recognized_by Lisch nodules
the presence of multiple neurofibromas
gptkbp:is_studied_in tumor biology
gptkbp:is_used_for freckling in armpits or groin
gptkbp:lifespan requires ongoing care
gptkbp:managed_by gptkb:hospital
multidisciplinary teams
gptkbp:occurs_in 1 in 3,000 births
gptkbp:requires genetic counseling
gptkbp:research genetics and oncology
gptkbp:risk_factor learning disabilities
certain cancers
gptkbp:scientific_classification genetic disorders
gptkbp:social_responsibility clinical criteria
childhood or early adulthood
gptkbp:subject public awareness campaigns
genetic research
gptkbp:supports patient advocacy groups
gptkbp:treatment targeted therapies
symptomatic management